CMB International Securities analyst Nika MA has maintained their bullish stance on CILJF stock, giving a Buy rating on April 30.
Nika MA has given his Buy rating due to a combination of factors including China Life Insurance Co’s strong financial performance and strategic improvements. The company’s net profit surged by 39.5% year-over-year in the first quarter of 2025, largely due to a significant reduction in insurance service expenses and improved claims experience for medical and health insurance products. Additionally, the company benefited from a favorable interest rate environment, which positively impacted its liability reserves.
Nika MA also highlighted the company’s improved asset-liability matching, which has led to a positive growth in net assets. Despite a modest increase in new business value compared to its peers, China Life’s focus on transitioning its product mix and maintaining a stable agency scale is expected to drive future growth. The stock’s valuation, trading at a relatively low price-to-earnings and price-to-book ratio, coupled with a positive outlook on asset-liability management, supports the Buy recommendation with a target price of HK$20.0.
MA covers the Financial sector, focusing on stocks such as Ping An Insurance Company of China, AIA Group, and China Life Insurance Co. According to TipRanks, MA has an average return of 5.3% and a 52.27% success rate on recommended stocks.
In another report released on April 30, DBS also maintained a Buy rating on the stock with a HK$19.00 price target.